Skip to main content
. 2017 Mar 13;8(21):34362–34373. doi: 10.18632/oncotarget.16156

Table 1. Clinical characteristics and Notch3 expression levels in patients with bladder cancer.

Variables n Notch3 expressiona P-value
Low (n = 19) High (n = 40)
Age (years)
 < 50 2 1 1 0.544
 ≥ 50 57 18 39
Gender
 Female 10 2 8 0.593
 Male 49 17 32
Tumor stage
 Ta 1 1 0 0.584
 Tis 2 1 1
 T1 12 5 7
 T2 12 4 8
 T3 20 5 15
 T4 12 3 9
Tumor size (cm3)
 < 5 39 13 26 0.795
 ≥ 5 20 6 14
Lymph node positivity
 No 45 15 30 0.996
 Yes 14 4 10
Distant metastasis
 M0 59 19 40 ---
Infiltration depth in bladder
 Ta, T1, Tis 15 6 9
 ≥ T2 44 13 31
Histological grade
 PUNLMP 8 4 4 0.291
 Low 28 10 18
 High 23 5 18

aHigh = IRS of Notch3 expression > 4 points as assessed by immunohistochemistry; Low = IRS of Notch3 expression < 4 points (See Figure 2).

PUNLMP: papillary urothelial neoplasms of low malignant potential.